{"id":"https://openalex.org/W1948967656","doi":"https://doi.org/10.1200/jco.1986.4.3.295","title":"Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience.","display_name":"Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience.","publication_year":1986,"publication_date":"1986-03-01","ids":{"openalex":"https://openalex.org/W1948967656","doi":"https://doi.org/10.1200/jco.1986.4.3.295","mag":"1948967656","pmid":"https://pubmed.ncbi.nlm.nih.gov/3512783"},"language":"en","primary_location":{"id":"doi:10.1200/jco.1986.4.3.295","doi":"https://doi.org/10.1200/jco.1986.4.3.295","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.1986.4.3.295","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030183182","display_name":"Dennis O. Dixon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D O Dixon","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110425581","display_name":"Barbara A. Neilan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B Neilan","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088731797","display_name":"Si\u00e2n Jones","orcid":"https://orcid.org/0000-0002-1042-2253","observed_orcids":["https://orcid.org/0000-0002-1042-2253","https://orcid.org/0000-0002-2399-1017"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S E Jones","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109316241","display_name":"David A. Lipschitz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D A Lipschitz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111492624","display_name":"TP Miller","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T P Miller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078350319","display_name":"Petre N. Grozea","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P N Grozea","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109005020","display_name":"Henry E. Wilson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H E Wilson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":10.6848,"has_fulltext":false,"cited_by_count":358,"citation_normalized_percentile":{"value":0.98423358,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"4","issue":"3","first_page":"295","last_page":"305"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11909","display_name":"Histiocytic Disorders and Treatments","score":0.006000000052154064,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-lymphoma","display_name":"advanced-stage lymphoma","score":0.6880000233650208},{"id":"https://openalex.org/keywords/age","display_name":"age","score":0.46299999952316284},{"id":"https://openalex.org/keywords/prognosis","display_name":"prognosis","score":0.5170000195503235},{"id":"https://openalex.org/keywords/chop-chemotherapy","display_name":"CHOP chemotherapy","score":0.765999972820282},{"id":"https://openalex.org/keywords/bleomycin","display_name":"bleomycin","score":0.8510000109672546},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.7630000114440918},{"id":"https://openalex.org/keywords/bcg","display_name":"BCG","score":0.9480000138282776},{"id":"https://openalex.org/keywords/levamisole","display_name":"levamisole","score":0.9980000257492065},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.7549999952316284},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.9929999709129333},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.6729999780654907},{"id":"https://openalex.org/keywords/southwest-oncology-group","display_name":"Southwest Oncology Group","score":0.7480000257492065}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9668949246406555},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.6454964280128479},{"id":"https://openalex.org/C2779725641","wikidata":"https://www.wikidata.org/wiki/Q1076228","display_name":"CHOP","level":3,"score":0.6164617538452148},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5671437978744507},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5469208359718323},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.475523978471756},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.4577741324901581},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.44918593764305115},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.39701616764068604}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001500","descriptor_name":"BCG Vaccine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007978","descriptor_name":"Levamisole","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011897","descriptor_name":"Random Allocation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.1986.4.3.295","doi":"https://doi.org/10.1200/jco.1986.4.3.295","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.1986.4.3.295","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:3512783","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3512783","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2598634573","display_name":null,"funder_award_id":"CA-16957","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5515545788","display_name":"SOUTHWEST ONCOLOGY GROUP CA13612","funder_award_id":"U10CA013612","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6886705019","display_name":"SOUTHWEST ONCOLOGY GROUP","funder_award_id":"U10CA004920","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1580788756","https://openalex.org/W1757201400","https://openalex.org/W1965708817","https://openalex.org/W1970356712","https://openalex.org/W1970938866","https://openalex.org/W1979300931","https://openalex.org/W1995586052","https://openalex.org/W2007345078","https://openalex.org/W2015807534","https://openalex.org/W2038252730","https://openalex.org/W2082102453","https://openalex.org/W2087526361","https://openalex.org/W2092253409","https://openalex.org/W2400454348","https://openalex.org/W2408732973"],"related_works":["https://openalex.org/W1970938866","https://openalex.org/W2002590283","https://openalex.org/W1579001322","https://openalex.org/W2408772935","https://openalex.org/W2624220783","https://openalex.org/W2344209648","https://openalex.org/W3031593977","https://openalex.org/W2531020449","https://openalex.org/W2126086632","https://openalex.org/W2013846265"],"abstract_inverted_index":{"To":[0],"study":[1],"the":[2,21,80,88,217],"influence":[3],"of":[4,23,132,152,194,198],"chronologic":[5],"age":[6,84,92,206],"on":[7,171],"treatment":[8,199],"outcome":[9],"in":[10,74,79,87,96,108,192,213],"patients":[11,40,135,143,154,165,170,222],"with":[12,42,49,55,70,144,168,209],"advanced,":[13],"diffuse":[14],"large-cell":[15],"(histiocytic)":[16],"lymphoma":[17],"(DHL),":[18],"we":[19],"reviewed":[20],"results":[22],"two":[24],"recent":[25],"Southwest":[26],"Oncology":[27],"Group":[28],"(SWOG)":[29],"clinical":[30],"trials.":[31],"From":[32],"1974":[33],"to":[34,82,90,230],"1982,":[35],"members":[36],"entered":[37],"307":[38],"eligible":[39],"treated":[41],"cyclophosphamide,":[43],"doxorubicin,":[44],"vincristine,":[45],"and":[46,53,94,99,117,140],"prednisone":[47],"(CHOP)":[48],"or":[50,56,62,138,157,196,225],"without":[51,57],"bleomycin,":[52],"CHOP":[54],"immunotherapy":[58],"using":[59],"BCG,":[60],"levamisole,":[61],"both.":[63],"Complete":[64],"response":[65],"(CR)":[66],"rates":[67],"declined":[68],"progressively":[69],"advancing":[71],"age:":[72],"65%":[73],"those":[75,97],"under":[76],"40,":[77],"60%":[78],"40":[81],"54":[83],"group,":[85,93],"55%":[86],"55":[89],"64":[91],"37%":[95],"65":[98,137,156,224],"older":[100,109,139,158,205,226],"(P":[101,121],"=":[102],".001).":[103,124],"Likewise,":[104],"survival":[105,177],"decreased":[106],"significantly":[107,185],"patients:":[110],"medians":[111],"were":[112,166,183,188],"101":[113],"+,":[114],"52,":[115],"34,":[116],"16":[118],"months,":[119],"respectively":[120],"less":[122],"than":[123],"Treatment":[125],"guidelines":[126],"included":[127],"an":[128],"initial":[129,160,218],"dose":[130,219],"reduction":[131,220],"50%":[133],"for":[134,141,221],"aged":[136,155,223],"younger":[142,169],"bone":[145],"marrow":[146],"compromise.":[147],"Despite":[148],"protocol":[149],"specifications,":[150],"23":[151],"81":[153],"received":[159],"full-dose":[161,173],"therapy.":[162],"When":[163],"these":[164],"compared":[167],"whom":[172],"chemotherapy":[174],"was":[175],"started,":[176],"curves,":[178],"but":[179],"not":[180],"CR":[181,195],"rates,":[182],"still":[184],"different.":[186],"There":[187],"no":[189],"significant":[190],"differences":[191],"duration":[193],"frequency":[197],"complications.":[200],"These":[201],"data":[202],"suggest":[203],"that":[204],"is":[207],"associated":[208],"a":[210],"worse":[211],"prognosis":[212],"advanced":[214],"DHL.":[215],"Moreover,":[216],"may":[227],"have":[228],"contributed":[229],"their":[231],"inferior":[232],"outcomes.":[233]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}
